Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHAI NASDAQ:IINN NASDAQ:LYRA NASDAQ:NAOV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.23-4.9%$0.22$0.12▼$3.67$11.08M0.07887,095 shs318,525 shsIINNInspira Technologies OXY B.H.N.$1.49-3.2%$0.69$0.40▼$1.66$18.80M2.24576,004 shs2.37 million shsLYRALyra Therapeutics$9.25+2.4%$9.58$3.81▼$37.50$12.30M0.24192,192 shs71,336 shsNAOVNanovibronix$0.96+4.5%$1.75$0.67▼$16.25$2.48M1.711.82 million shs3.71 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US+2.54%+0.49%+12.22%+36.72%-91.86%IINNInspira Technologies OXY B.H.N.+31.06%+81.18%+112.12%+156.75%+13.24%LYRALyra Therapeutics+0.17%+0.78%-62.81%+80.60%-33.60%NAOVNanovibronix-1.35%-0.95%+2.04%-88.12%-88.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDHAIDIH Holding US0.6604 of 5 stars0.05.00.00.00.61.70.0IINNInspira Technologies OXY B.H.N.2.8437 of 5 stars3.55.00.00.01.81.70.0LYRALyra Therapeutics1.6156 of 5 stars3.22.00.00.00.61.70.6NAOVNanovibronix0.0795 of 5 stars0.02.00.00.00.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 0.00N/AN/AN/AIINNInspira Technologies OXY B.H.N. 3.00Buy$2.0034.23% UpsideLYRALyra Therapeutics 2.33Hold$100.00981.08% UpsideNAOVNanovibronix 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NAOV, LYRA, DHAI, and IINN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/2/2025IINNInspira Technologies OXY B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$2.00(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$64.47M0.17N/AN/A($0.80) per share-0.29IINNInspira Technologies OXY B.H.N.N/AN/AN/AN/A$0.34 per shareN/ALYRALyra Therapeutics$1.53M8.04N/AN/A$8.86 per share1.04NAOVNanovibronix$2.56M0.97N/AN/A$1.84 per share0.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%N/A-25.97%N/AIINNInspira Technologies OXY B.H.N.-$11.05MN/A0.00∞N/AN/AN/AN/AN/ALYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)NAOVNanovibronix-$3.70M-$13.53N/A∞N/A-210.82%-54.73%-38.63%8/13/2025 (Estimated)Latest NAOV, LYRA, DHAI, and IINN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025NAOVNanovibronixN/A-$3.98N/A-$3.98N/A$1.02 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/AIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/ANAOVNanovibronixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/A0.510.34IINNInspira Technologies OXY B.H.N.0.092.021.89LYRALyra TherapeuticsN/A2.962.96NAOVNanovibronixN/A0.470.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%IINNInspira Technologies OXY B.H.N.12.72%LYRALyra Therapeutics95.62%NAOVNanovibronix16.39%Insider OwnershipCompanyInsider OwnershipDHAIDIH Holding US49.58%IINNInspira Technologies OXY B.H.N.29.40%LYRALyra Therapeutics3.25%NAOVNanovibronix6.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A47.34 million23.87 millionN/AIINNInspira Technologies OXY B.H.N.2012.62 million8.91 millionNot OptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableNAOVNanovibronix202.58 million2.42 millionNot OptionableNAOV, LYRA, DHAI, and IINN HeadlinesRecent News About These CompaniesNanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation - MorningstarJune 27, 2025 | morningstar.comMNanoVibronix, Inc. (NAOV) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comNanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line NavigationJune 26, 2025 | finance.yahoo.comNanoVibronix has a next-gen robotic system under developmentJune 26, 2025 | massdevice.comNanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube PlacementJune 24, 2025 | businesswire.comENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance SystemJune 11, 2025 | finance.yahoo.comNanoVibronix appoints new CEO after acquisitionJune 5, 2025 | uk.investing.comNanoVibronix Appoints Doron Besser As Chief Executive OfficerJune 5, 2025 | nasdaq.comNanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’June 4, 2025 | msn.comNanoVibronix Announces CEO TransitionJune 4, 2025 | finance.yahoo.comNanoVibronix refutes false stock offering claimsMay 29, 2025 | investing.comNanoVibronix Responds to False PostMay 28, 2025 | businesswire.comMajor Louisiana Hospital Selects ENvue System for Feeding Tube ProceduresMay 28, 2025 | finance.yahoo.comNanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and WarrantsMay 16, 2025 | businesswire.comNanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and WarrantsMay 15, 2025 | finance.yahoo.comNanoVibronix Announces Results from UroShield™ Case SeriesMay 12, 2025 | businesswire.comNanoVibronix Regains Nasdaq ComplianceApril 11, 2025 | finance.yahoo.comNanoVibronix, Inc.April 10, 2025 | cnn.comNanoVibronix announces board member resignationApril 5, 2025 | uk.investing.comNanoVibronix renews, expands exclusive distribution agreement with DukehillApril 3, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNAOV, LYRA, DHAI, and IINN Company DescriptionsDIH Holding US NASDAQ:DHAI$0.23 -0.01 (-4.92%) Closing price 04:00 PM EasternExtended Trading$0.24 +0.01 (+3.42%) As of 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Inspira Technologies OXY B.H.N. NASDAQ:IINN$1.49 -0.05 (-3.25%) Closing price 04:00 PM EasternExtended Trading$1.48 -0.01 (-1.01%) As of 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Lyra Therapeutics NASDAQ:LYRA$9.25 +0.22 (+2.44%) Closing price 04:00 PM EasternExtended Trading$9.13 -0.12 (-1.30%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Nanovibronix NASDAQ:NAOV$0.96 +0.04 (+4.53%) Closing price 04:00 PM EasternExtended Trading$0.98 +0.02 (+1.77%) As of 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
